Dow Up 0.76% Nasdaq Up 0.69%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
5.09 Up 0.35(7.38%) Oct 24, 4:00PM EDT
Prev Close:4.74
Open:4.75
Bid:3.49 x 4000
Ask:5.25 x 500
1y Target Est:24.00
Beta:1.09
Next Earnings Date:N/A
Day's Range:4.75 - 5.09
52wk Range:4.28 - 19.11
Volume:145,773
Avg Vol (3m):675,372
Market Cap:112.20M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTUp 7.38%112.20M
MNTAUp 0.18%567.35M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.03
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback